bpc-157 tendon repair BPC-157: The Recovery Peptide Backed by Clinical Research | PeptIQ Blog Everyone wants the “healing peptide”…,

For recovery enhancement, performance optimisation, or longevity goals in healthy people, until a randomised, placebo-controlled trial in a defined population with an objective primary endpoint and pharmacovigilance over a clinically meaningful duration produces data we do not currently have, we just don't have good evidence of benefit, let alone safety

Several studies have shown that PEA is effective in reducing symptoms of IBS, such as abdominal pain and bloating

A.Abdel-WahhabM

Overall, discontinuation rates due to adverse events were low, with 5.9% for CagriSema versus 3.5% for placebo in REDEFINE 1 and 8.4% with CagriSema versus 3% with placebo in REDEFINE 2